SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-21-017648
Filing Date
2021-05-17
Accepted
2021-05-17 16:06:01
Documents
73
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10024479_10q.htm 10-Q 729103
2 EXHIBIT 31.1 brhc10024479_ex31-1.htm EX-31.1 8009
3 EXHIBIT 32.1 brhc10024479_ex32-1.htm EX-32.1 4660
10 image00001.jpg GRAPHIC 4416
  Complete submission text file 0001140361-21-017648.txt   4747010

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT btx-20210331.xml EX-101.INS 658537
5 XBRL TAXONOMY EXTENSION SCHEMA btx-20210331.xsd EX-101.SCH 60848
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE btx-20210331_cal.xml EX-101.CAL 55470
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE btx-20210331_def.xml EX-101.DEF 290396
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE btx-20210331_lab.xml EX-101.LAB 722416
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btx-20210331_pre.xml EX-101.PRE 421179
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-11460 | Film No.: 21930417
SIC: 2834 Pharmaceutical Preparations